173 related articles for article (PubMed ID: 15379648)
1. The Use of DNA Microarrays to Investigate the Pharmacogenomics of Drug Response in Living Systems.
Villeneuve DJ; Parissenti AM
Curr Top Med Chem; 2004; 4(13):1327-1343. PubMed ID: 15379648
[TBL] [Abstract][Full Text] [Related]
2. DNA microarrays and pharmacogenomics.
Meloni R; Khalfallah O; Biguet NF
Pharmacol Res; 2004 Apr; 49(4):303-8. PubMed ID: 15202510
[TBL] [Abstract][Full Text] [Related]
3. Analysis of DNA microarray data.
Hackl H; Sanchez Cabo F; Sturn A; Wolkenhauer O; Trajanoski Z
Curr Top Med Chem; 2004; 4(13):1357-70. PubMed ID: 15379650
[TBL] [Abstract][Full Text] [Related]
4. Application of DNA microarrays in pharmacogenomics and toxicogenomics.
Chin KV; Kong AN
Pharm Res; 2002 Dec; 19(12):1773-8. PubMed ID: 12523654
[TBL] [Abstract][Full Text] [Related]
5. Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics.
Hardiman G
Pharmacogenomics; 2008 Jan; 9(1):5-9. PubMed ID: 18154443
[No Abstract] [Full Text] [Related]
6. Microarrays in pharmacogenomics--advances and future promise.
Chicurel ME; Dalma-Weiszhausz DD
Pharmacogenomics; 2002 Sep; 3(5):589-601. PubMed ID: 12223046
[TBL] [Abstract][Full Text] [Related]
7. Microarrays: spotlight on gene function and pharmacogenomics.
Nees M; Woodworth CD
Curr Cancer Drug Targets; 2001 Aug; 1(2):155-75. PubMed ID: 12188888
[TBL] [Abstract][Full Text] [Related]
8. Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics.
Hoehe MR; Timmermann B; Lehrach H
Curr Pharm Biotechnol; 2003 Dec; 4(6):351-78. PubMed ID: 14683431
[TBL] [Abstract][Full Text] [Related]
9. Better therapeutics through microarrays.
Gerhold DL; Jensen RV; Gullans SR
Nat Genet; 2002 Dec; 32 Suppl():547-51. PubMed ID: 12454652
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics.
Ross JS; Schenkein DP; Kashala O; Linette GP; Stec J; Symmans WF; Pusztai L; Hortobagyi GN
Adv Anat Pathol; 2004 Jul; 11(4):211-20. PubMed ID: 15220824
[TBL] [Abstract][Full Text] [Related]
11. Gene expression-driven diagnostics and pharmacogenomics in cancer.
Wang Y
Curr Opin Mol Ther; 2005 Jun; 7(3):246-50. PubMed ID: 15977422
[TBL] [Abstract][Full Text] [Related]
12. Representational oligonucleotide microarray analysis (ROMA) in pharmacogenomics.
Liu ET
Pharmacogenomics J; 2004; 4(2):74-6. PubMed ID: 15042143
[No Abstract] [Full Text] [Related]
13. Microarrays in pharmacogenomics.
Chen JJ
J Biopharm Stat; 2004 Aug; 14(3):535-7. PubMed ID: 15468750
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics, pharmacogenomics and airway disease.
Hall IP
Respir Res; 2002; 3(1):10. PubMed ID: 11806845
[TBL] [Abstract][Full Text] [Related]
15. Advances in pharmacogenomics technologies.
Bhasker CR; Hardiman G
Pharmacogenomics; 2010 Apr; 11(4):481-5. PubMed ID: 20350126
[TBL] [Abstract][Full Text] [Related]
16. Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips.
Fu LM
Tuberculosis (Edinb); 2006 Mar; 86(2):134-43. PubMed ID: 16246625
[TBL] [Abstract][Full Text] [Related]
17. Reducing false positive findings in statistical analysis of pharmacogenomic biomarker studies using high-throughput technologies.
Matsui S
Curr Drug Saf; 2006 May; 1(2):135-41. PubMed ID: 18690924
[TBL] [Abstract][Full Text] [Related]
18. National Oncology Forum: perspectives for the year 2000.
DeVita VT; Bleickardt EW
Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
[TBL] [Abstract][Full Text] [Related]
19. Analyzing array data using supervised methods.
Ringnér M; Peterson C; Khan J
Pharmacogenomics; 2002 May; 3(3):403-15. PubMed ID: 12052147
[TBL] [Abstract][Full Text] [Related]
20. Using microarrays to predict resistance to chemotherapy in cancer patients.
Lee CH; Macgregor PF
Pharmacogenomics; 2004 Sep; 5(6):611-25. PubMed ID: 15335284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
